The RP2 Panel provides results in less than two hours for more than 20 viruses and bacteria that cause common respiratory infections with similar symptoms, including COVID-19, flu, bronchitis and ...

BUFFALO, N.Y., July 2, 2019 /PRNewswire-PRWeb/ -- ZeptoMetrix™ Corporation (ZMC) has released a new 20-member respiratory verification panel for use in laboratories engaged in utilizing ...

for its ePlex® Respiratory Pathogen Panel 2 (RP2). The molecular test provides results in less than two hours for more than 20 viruses and bacteria that cause common and often serious respiratory ...

Separately, the company also announced that its ePlex Respiratory Pathogen Panel 2 (or RP2) has received Emergency Use Authorization from the US FDA. Currently, GenMark (GNMK) expects its 3Q ...

The company also submitted an Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration for the ePlex® Respiratory Pathogen 2 (RP2) Panel earlier this month. The ePlex RP2 Panel ...

The qualitative Respiratory Validation Panel Global (NATRVP-2, ZeptoMetrix Corporation, Buffalo, New York) was quantified by real-time qPCR. External plasmid standards were used to determine the ...

from the U.S. Food and Drug Administration for its ePlex® Respiratory Pathogen Panel 2 (RP2). In less than two hours, the test provides results for more than 20 viruses and bacteria that cause ...

Molecular syndromic test for COVID-19, influenza and other common respiratory pathogens helps health care professionals prepare for flu season RP2 Panel at a Glance RP2 provides results in less ...

Molecular syndromic test for COVID-19, influenza and other common respiratory pathogens helps health care professionals prepare for flu season RP2 Panel at a Glance GenMark's ePlex Respiratory ...